acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome
MeSH: C536000ORPHA: 903011 Treatment Available
Overview
This syndrome is characterised by the association of acanthosis nigricans, insulin resistance, severe muscle cramps and acral hypertrophy
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| metformin | oral tablets 500mg/850mg/1000mg, extended-release tablets 500mg/750mg | FDA Approved | 9 | 2d |
Clinical Presentation
Signs and symptoms associated with acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome, sourced from HPO and Orphanet clinical annotations.
Enlarged kidneyPolycystic ovariesInsulin-resistant diabetes mellitusElevated circulating growth hormone concentrationInsulin resistanceAcanthosis nigricansHirsutismMuscle spasmEnlarged polycystic ovaries
Classification & Codes
MeSH Code
C536000Orphanet Code
ORPHA:90301acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome
| MeSH | C536000 |
| Orphanet | ORPHA:90301 |
| Treatments | 1 drug(s) |
| Symptoms on record | 9 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO